Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125609831 | 12560983 | 1 | I | 20160704 | 20160715 | 20160715 | EXP | IT-TEVA-675341ACC | TEVA | PIERIMARCHI P. PRESCRIPTIVE APPROPRIATENESS AND ELDERLY PATIENTS: IS NECESSARY A CHANGE OF COURSE?. ABOUTPHARMA. 2016 JUL 01;22-24. | 0.00 | E | Y | 0.00000 | 20160715 | COUNTRY NOT SPECIFIED | IT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125609831 | 12560983 | 1 | PS | AMLODIPINE | AMLODIPINE BESYLATE | 1 | UNKNOWN | U | 76846 | ||||||||||
| 125609831 | 12560983 | 2 | I | SIMVASTATIN. | SIMVASTATIN | 1 | UNKNOWN | U | 76052 |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125609831 | 12560983 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125609831 | 12560983 | Drug interaction | |
| 125609831 | 12560983 | Myopathy | |
| 125609831 | 12560983 | Renal failure | |
| 125609831 | 12560983 | Rhabdomyolysis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |